546 related articles for article (PubMed ID: 31838837)
1. Senolytics and Senostatics: A Two-Pronged Approach to Target Cellular Senescence for Delaying Aging and Age-Related Diseases.
Kang C
Mol Cells; 2019 Dec; 42(12):821-827. PubMed ID: 31838837
[TBL] [Abstract][Full Text] [Related]
2. Flavonoids in Skin Senescence Prevention and Treatment.
Domaszewska-Szostek A; Puzianowska-Kuźnicka M; Kuryłowicz A
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201952
[TBL] [Abstract][Full Text] [Related]
3. A guide to senolytic intervention in neurodegenerative disease.
Lee S; Wang EY; Steinberg AB; Walton CC; Chinta SJ; Andersen JK
Mech Ageing Dev; 2021 Dec; 200():111585. PubMed ID: 34627838
[TBL] [Abstract][Full Text] [Related]
4. Senescence and the SASP: many therapeutic avenues.
Birch J; Gil J
Genes Dev; 2020 Dec; 34(23-24):1565-1576. PubMed ID: 33262144
[TBL] [Abstract][Full Text] [Related]
5. Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies.
Khalil R; Diab-Assaf M; Lemaitre JM
Cells; 2023 Mar; 12(6):. PubMed ID: 36980256
[TBL] [Abstract][Full Text] [Related]
6. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases.
Lagoumtzi SM; Chondrogianni N
Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756
[TBL] [Abstract][Full Text] [Related]
7. Cellular senescence in the lung across the age spectrum.
Parikh P; Wicher S; Khandalavala K; Pabelick CM; Britt RD; Prakash YS
Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L826-L842. PubMed ID: 30785345
[TBL] [Abstract][Full Text] [Related]
8. Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span.
Robbins PD; Jurk D; Khosla S; Kirkland JL; LeBrasseur NK; Miller JD; Passos JF; Pignolo RJ; Tchkonia T; Niedernhofer LJ
Annu Rev Pharmacol Toxicol; 2021 Jan; 61():779-803. PubMed ID: 32997601
[TBL] [Abstract][Full Text] [Related]
9. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities.
Tchkonia T; Zhu Y; van Deursen J; Campisi J; Kirkland JL
J Clin Invest; 2013 Mar; 123(3):966-72. PubMed ID: 23454759
[TBL] [Abstract][Full Text] [Related]
10. Targeting cellular senescence based on interorganelle communication, multilevel proteostasis, and metabolic control.
Cavinato M; Madreiter-Sokolowski CT; Büttner S; Schosserer M; Zwerschke W; Wedel S; Grillari J; Graier WF; Jansen-Dürr P
FEBS J; 2021 Jun; 288(12):3834-3854. PubMed ID: 33200494
[TBL] [Abstract][Full Text] [Related]
11. Keeping the senescence secretome under control: Molecular reins on the senescence-associated secretory phenotype.
Malaquin N; Martinez A; Rodier F
Exp Gerontol; 2016 Sep; 82():39-49. PubMed ID: 27235851
[TBL] [Abstract][Full Text] [Related]
12. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease.
Hickson LJ; Langhi Prata LGP; Bobart SA; Evans TK; Giorgadze N; Hashmi SK; Herrmann SM; Jensen MD; Jia Q; Jordan KL; Kellogg TA; Khosla S; Koerber DM; Lagnado AB; Lawson DK; LeBrasseur NK; Lerman LO; McDonald KM; McKenzie TJ; Passos JF; Pignolo RJ; Pirtskhalava T; Saadiq IM; Schaefer KK; Textor SC; Victorelli SG; Volkman TL; Xue A; Wentworth MA; Wissler Gerdes EO; Zhu Y; Tchkonia T; Kirkland JL
EBioMedicine; 2019 Sep; 47():446-456. PubMed ID: 31542391
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria-targeted senotherapeutic interventions.
Atayik MC; Çakatay U
Biogerontology; 2022 Aug; 23(4):401-423. PubMed ID: 35781579
[TBL] [Abstract][Full Text] [Related]
14. Cellular senescence in bone.
Farr JN; Khosla S
Bone; 2019 Apr; 121():121-133. PubMed ID: 30659978
[TBL] [Abstract][Full Text] [Related]
15. Senolytics: Eliminating Senescent Cells and Alleviating Intervertebral Disc Degeneration.
Wu Y; Shen S; Shi Y; Tian N; Zhou Y; Zhang X
Front Bioeng Biotechnol; 2022; 10():823945. PubMed ID: 35309994
[TBL] [Abstract][Full Text] [Related]
16. Senolytics and senostatics as adjuvant tumour therapy.
Short S; Fielder E; Miwa S; von Zglinicki T
EBioMedicine; 2019 Mar; 41():683-692. PubMed ID: 30737084
[TBL] [Abstract][Full Text] [Related]
17. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.
Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
FEBS J; 2023 Mar; 290(5):1362-1383. PubMed ID: 35015337
[TBL] [Abstract][Full Text] [Related]
18. New Horizons: Novel Approaches to Enhance Healthspan Through Targeting Cellular Senescence and Related Aging Mechanisms.
Tchkonia T; Palmer AK; Kirkland JL
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1481-e1487. PubMed ID: 33155651
[TBL] [Abstract][Full Text] [Related]
19. Targeting cellular senescence: A promising approach in respiratory diseases.
Sugimoto M
Geriatr Gerontol Int; 2024 Mar; 24 Suppl 1():60-66. PubMed ID: 37604771
[TBL] [Abstract][Full Text] [Related]
20. Targeting Senescent Cells: Possible Implications for Delaying Skin Aging: A Mini-Review.
Velarde MC; Demaria M
Gerontology; 2016; 62(5):513-8. PubMed ID: 27031122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
